Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
This is to inform that the Company has received
an order dated November 12, 2024, from COFEPRIS (Comisi n Federal para la Protecci n Contra Riesgos Sanitarios) health department
of Mexico. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read
with Schedule III Para A Sub Para 20 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as hereunder:
| A | Name of the authority | : | COFEPRIS (Comisi n Federal para la Protecci n Contra Riesgos Sanitarios) |
| B | Nature and details of the action(s) taken, initiated or order(s) passed | : | The drug regulatory body of Mexico (Comisi n Federal para la Protecci n contra Riesgos Sanitarios) has imposed a penalty of MXN 651, 420 (~INR 27 Lakh) on the Company for deviation from prescribed guidelines in filing intimation of import of a reference standard for one of our APIs. Additionally, the fine was imposed due to an error in the date of the invoice and also name of the reference standard Vs import license. |
| C | Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority | : | 13 th November 2024 |
| D | Details of the violation(s)/ contravention(s) committed or alleged to be committed | : | As stated in "B" above |
| E | Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible | : | MXN 651,420 (~INR 27 Lakh) |
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer and Head-CSR